Skip to content

Analysis of association between ANCA-associated vasculitis and ApoA1-VAP2 complex

Analysis of association between ANCA-associated vasculitis and ApoA1-VAP2 complex - Analysis of association between ANCA-associated vasculitis and ApoA1-VAP2 complex

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043634
Enrollment
60
Registered
2021-04-01
Start date
2021-02-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ANCA-associated vasculitis

Interventions

None listed

Sponsors

Chiba University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ANCA-associated vasculitis patients who fulfilled the definition of 2012 Chapel Hill Consensus Conference

Exclusion criteria

Exclusion criteria: 1. Less than 20 years old 2. Eosinophilic granulomatosis with polyangiitis

Design outcomes

Primary

MeasureTime frame
serum ApoA1-VAP2 complex levels in active/inactive ANCA-associated vasculitis and healthy control

Countries

Japan

Contacts

Public ContactShunsuke Furuta

Chiba University Hospital Allergy and Clinical Immunology

shfuruta@gmail.com0432227171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026